Skip to Main Content

Paper Details

Integrative proteomics in prostate cancer uncovers robustness against genomic and transcriptomic aberrations during disease progression.
Nat Commun
108
2018
Author NameAffiliation
Leena LatonenProstate Cancer Research Center, Faculty of Medicine and Life Sciences and BioMediTech Institute, University of Tampere
Leena LatonenTampere University Hospital
Matti AnnalaProstate Cancer Research Center, Faculty of Medicine and Life Sciences and BioMediTech Institute, University of Tampere
Matti NykterProstate Cancer Research Center, Faculty of Medicine and Life Sciences and BioMediTech Institute, University of Tampere
Matti NykterTampere University Hospital
Tapio VisakorpiProstate Cancer Research Center, Faculty of Medicine and Life Sciences and BioMediTech Institute, University of Tampere
Tapio VisakorpiTampere University Hospital
  • 1 - 7

Datasets